Jeong Min Yu, MD, MS

Experience

• 

  Simpson Querrey Institute @ Northwestern University

  Dec 2011 - Feb 2014

  Research Assistant at Stupp Lab

  Conduct research in a group of 45 members in investigating peptide-based biomaterials with a focus on cell-material interactions for applications in bone regeneration and neuron development. Present results professionally on a monthly basis in subgroups and group meetings. Adapt and optimize protocols and thoroughly document all experimental procedures and results. Design and perform experiments to further understand and advance the project; examine outcomes. Compose part of research paper for publication. Manuscript entitled "Cell death instructed by supramolecular cohesion of nanostructures" has been accepted by Nature Communications on 12/13/2013 for publication. I am a contributing author of this manuscript. 10hrs/week during school year; 30hrs/week after graduation. Show less

• 

  Northwestern University - The Feinberg School of Medicine

  May 2015 - May 2018

  Research Assistant at Dr. Amy S Paller Lab in the Department of Dermatology

  Conduct research in receptor signaling involved in diabetic wound healing

• 

  Cedars-Sinai

  Jun 2018 - Jun 2021

  - Evaluated how increased gene expression of a membrane transporter of folate, SLC19A1, in the peripheral blood of patients with systemic lupus erythematosus (SLE), compared to healthy controls, could suggest possible pathogenic implications. Won the Medical and Pediatric Resident Research Award from the Rheumatology Research Foundation to present this work at the American College of Rheumatology in 2020.- Investigated whether skin inflammation genes associated with discoid lupus erythematosus is differentially expressed peripherally in SLE patients with and without lupus specific skin lesions. Won Third place for the Best Scientific Abstract Competition, the 2020 Society of General Internal Medicine California-Hawaii Regional Meeting for this work. Show less - Lead the inpatient service team for six months per year, covering the general ward, ICUs, heart failure/heart transplant service, and the hematology/oncology wards.- Rotated through inpatient subspecialty consult services, caring for acutely ill patients and complex cases.- Provided care for primary care patients through the continuity clinic every fifth week.- Taught medical students and interns at the bedside and during rounds on General Medicine Wards, Medical Intensive Care Unit, Cardiac Intensive Care Unit, and Hematology-Oncology Inpatient Ward rotations.- Presented quarterly Morning Reports to Internal Medicine residents and interns.- Board certified in internal medicine in 2021 Show less

  • Medicine Resident Researcher

    Nov 2018 - Jun 2021

  • Internal Medicine Resident

    Jun 2018 - Jun 2021
• 

  Weill Cornell Medicine

  Jul 2021 - Jun 2024

  Rheumatology Fellow
• 

  Hospital for Special Surgery

  Jul 2021 - Jun 2024

  - Participated in seven hour-long registry visits for a study to evaluate the efficacy and safety of ABC008 forInclusion Body Myositis, a phase II/III randomized, double-blind, placebo-controlled, multicenter study sponsored by Abcuro, Inc. (ClinicalTrials.gov ID: NCT05721573).- Certified as the Hospital for Special Surgery (HSS) clinical rater for the Abcuro ABC008-IBM-201 study andperformed registry visits as a Sub-Investigator for the study.- Drafted the full study protocol for an investigator-initiated study of an investigational drug for Primary Sjogren’s disease as a Sub-Investigator.- Participated in hour-long weekly Scleroderma Vasculitis Myositis Center clinical trials research meetings with other clinical trialists at HSS. Show less - Evaluated psychometric properties of a novel two-part patient reported outcome (PRO) developed to assess skin symptoms in a large registry of patients with systemic sclerosis (SSc), a rare systemic autoimmune disease with skin scarring, to generate evidence to support its further use.- Led a tri-institutional and multi-disciplinary collaboration through regular meetings.- first author of a manuscript: Yu JM, VanBuren JM, Child A, et al. Psychometric Evaluation of the Scleroderma Skin Questionnaire: A Novel Patient-Reported Outcome for Skin Disease in Patients With Systemic Sclerosis. J Rheumatol. Published online February 1, 2025. doi:10.3899/jrheum.2024-0736 Show less • trained in three hospitals: Hospital for Special Surgery, Weill Cornell Medical Center, Memorial Sloan-Kettering Cancer Center• Treated and managed a wide spectrum of rheumatologic conditions in outpatient clinics for three half-days per week and during the inpatient consult service.• Served as the rheumatologist for a panel of 180 patients, coordinating complex care through an interdisciplinary team of nurses and social workers, as well as collaborating with a number of specialists across the city to provide comprehensive care.• Supervised one to four residents in the inpatient consult service and outpatient clinics, providing regular feedback to each supervisee on their presentations and consult notes, and teaching them clinical pearls related to patient cases.• Participated in division-wide weekly Journal Club and Grand Rounds, as well as five fellowship-specificconferences.• Board certified in Rheumatology in 2023 Show less

  • Sub-Investigator

    Dec 2023 - Jun 2024

  • Rheumatology Fellow Researcher

    Jan 2022 - Jun 2024

  • Clinical Rheumatology Fellow

    Jul 2021 - Jun 2024
• 

  Memorial Sloan Kettering Cancer Center

  Jul 2021 - Jun 2024

  Rheumatology Fellow
• 

  FDA

  Oct 2024 - now

  Medical Officer

  Center for Drug Evaluation and Research (CDER), Office of New Drugs (OND), Office of Immunology & Inflammation (OII), Division of Rheumatology & Transplant Medicine (DRTM)- Successfully completed primary reviews of five Investigational New Drug (IND) applications and am currently serving as the primary clinical reviewer for two Biologics License Applications (BLAs). Significant experience with various industry meetings (Type B, Type C, Type D) and I am comfortable reviewing new protocols, protocol amendments, and safety reports, as well as reassessing safety and efficacy determinations.- Provide scientific, clinical, and regulatory oversight for investigational studies conducted during drug development.- Serve as a clinical expert on a multidisciplinary team in the review and evaluation of clinical scientific data to assess new drugs, biologics, and biosimilar biologics.- Review proposed drug labels to determine whether they contain truthful claims about the product’s effectiveness and safety. Show less